Deutsche Bank’s Dimension Therapeutics, Inc DMTX Stock Holding History

Deutsche Bank’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,231	Closed	-$19K	–	5384
2017 Q3	$19K	Sell	3,231 -60	-2%	-$156	﹤0.01%	4577
2017 Q2	$4K	Sell	3,291 -2,857	-46%	-$3.88K	﹤0.01%	4791
2017 Q1	$10K	Sell	6,148 -10,859	-64%	-$28.8K	﹤0.01%	4628
2016 Q4	$72K	Buy	17,007 +14,847	+687%	+$79K	﹤0.01%	4225
2016 Q3	$17K	Buy	2,160 +287	+15%	+$2.08K	﹤0.01%	4581
2016 Q2	$11K	Buy	1,873 +1,028	+122%	+$7.83K	﹤0.01%	4899
2016 Q1	$6K	Sell	845 -563	-40%	-$4.43K	﹤0.01%	4943
2015 Q4	$15K	Buy	+1,408	New	+$17.8K	﹤0.01%	4842

Deutsche Bank's DMTX Position: Q4 2017 in Review

Deutsche Bank sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 3,231 shares — an estimated $19K sold.

Deutsche Bank first reported a position in DMTX in Q4 2015 and held it in 8 quarters. The position peaked at $72K in Q4 2016. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

Deutsche Bank reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
Deutsche Bank sold 3,231 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $19K.
Deutsche Bank first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 8 quarters.
Deutsche Bank's Dimension Therapeutics, Inc position peaked at $72K in Q4 2016.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Deutsche Bank's 13F filing for Q4 2017, filed 14 Feb 2018.